Drug testing certainly is cropping up in the media a lot recently. Apparently ORaline IV was once the best product on the market but did have some problems. The question now is can the company make the stated improvements to oraline IV that will give it a competitive edge over those oral fluid tests already available so it can gain market share?
Orasure, over on the NASDAQ seems to be the only other listed company that I can find that deals in oral fluid drug testing.
SBN Price at posting:
1.1¢ Sentiment: Hold Disclosure: Held